A Systematic Review and Network Meta-Analysis of Chinese Trials on Antihypertensive Medications for Managing Hyperuricemia in Hypertensive Patients - Top-Institutions - MDSpire

A Systematic Review and Network Meta-Analysis of Chinese Trials on Antihypertensive Medications for Managing Hyperuricemia in Hypertensive Patients

  • By

  • Juan Wu

  • Hong Di

  • Yun Zhang

  • Xuejun Zeng

  • December 2, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Nephrology
    • Clinical Pharmacology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Nephrology
    • Epidemiology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Nephrology
    • Internal Medicine

  • #4

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Nephrology
    • Clinical Research

  • #5

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Cardiology
    • Nephrology
    • Clinical Pharmacology

Original Source(s)

A Systematic Review and Network Meta-Analysis of Chinese Trials on Antihypertensive Medications for Managing Hyperuricemia in Hypertensive Patients

  • by Juan Wu, Hong Di, Yun Zhang, Xuejun Zeng

  • December 2, 2025

Related Content

School-Based Screening Detected Undiagnosed Hypertension

Novel program enabled large-scale blood pressure screening and identified elevated readings in community setting.

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Grip Strength Plus Waist Size May Flag Risk T2D Risk

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.